PRELIMINARY TIMETABLE
Dated 05.12.18 – Subject to Change
Rafi Gidron
Founder and Chairman, Israel Brain TechnologiesRafi Gidron
Founder and Chairman, Israel Brain Technologies
Karin Mayer Rubinstein
CEO, IATI, IsraelKarin Mayer Rubinstein
CEO, IATI, IsraelBrainMind is an ecosystem and platform for impact-oriented company creation in brain and mind science. Brain science is in the midst of a transformative step change in capacity, akin to the sequencing of the human genome in genetics or development of nuclear fission in physics. Emerging technologies with unprecedented ability to access and manipulate the brain and mind are being rapidly developed in the private sector, where public oversight is limited. As a species, we must proactively navigate this watershed era in neuroscience. The BrainMind ecosystem will catalyze impact-maximizing innovation in brain science with new forms of capital and leadership support for non venture-backable ideas with the most potential to benefit humanity. Less than a year old, the platform has attracted Stanford, MIT, and Oxford and a growing list of academic collaborators. BrainMind’s leaders Michael McCullough, Ed Boyden, Laura Roberts, and Reid Hoffman have leveraged the private sector to draw together top philanthropists/foundations (>$100BN in capital), and the world’s top investors and entrepreneurs in this ecosystem to support these pivotal ideas from the lab to society.
Michael McCullough
Entrepreneur In Residence at Greylock Partners, Investor, Founder BrainMind & ER doc, USA Short BioMichael McCullough
Entrepreneur In Residence at Greylock Partners, Investor, Founder BrainMind & ER doc, USANetworking Break
TBC
Panel discussion with audience interaction. Panelists:
Anya Eldan
Israel Innovation AuthorityAnya Eldan
Israel Innovation Authority
Dan Schwarzman
CEO, MindUp, IsraelDan Schwarzman
CEO, MindUp, Israel
Ittai Harel
Managing General Partner, Pitango Venture Capital
TBC
TBC
Startups Spotlight
Q&A
START-UP COMPETITION FINALIST PRESENTATIONS
CLOSING THE LOOP ON PARKINSON'S DISEASE – FROM PHYSIOLOGY TO TREATMENT AND BACK
Hagai Bergman
President, Israel society for Neuroscience (ISFN), Professor of Physiology, The Hebrew University of Jerusalem; IsraelSimone and Bernard Guttman Chair in Brain Research President, Israel society for Neuroscience (ISFN) Past president (2010-2013), International Basal Ganglia Society (IBAGS) Department of Medical Neurobiology (Physiology), Institute of medical research – Israel Canada (IMRIC), Faculty of Medicine The Edmond and Lily Safra Center for Brain Sciences (ELSC)
The Hebrew university, Jerusalem, ISRAEL Department of Neurosurgery Hadassah medical center, Jerusalem, Israel
Hagai Bergman
President, Israel society for Neuroscience (ISFN), Professor of Physiology, The Hebrew University of Jerusalem; IsraelTBC
Timothy Denison
Professor of Engineering Science, Royal Academy Chair in Emerging Technology, University of Oxford, UKTimothy Denison, PhD
Royal Academy of Engineering Chair in Emerging Technologies
Department of Engineering Science
Nuffield Department of Clinical Neuroscience
MRC Brain Network Dynamics Unit
Oxford University
Timothy Denison
Professor of Engineering Science, Royal Academy Chair in Emerging Technology, University of Oxford, UKPanel Discussion
Hagai Bergman
President, Israel society for Neuroscience (ISFN), Professor of Physiology, The Hebrew University of Jerusalem; IsraelSimone and Bernard Guttman Chair in Brain Research President, Israel society for Neuroscience (ISFN) Past president (2010-2013), International Basal Ganglia Society (IBAGS) Department of Medical Neurobiology (Physiology), Institute of medical research – Israel Canada (IMRIC), Faculty of Medicine The Edmond and Lily Safra Center for Brain Sciences (ELSC)
The Hebrew university, Jerusalem, ISRAEL Department of Neurosurgery Hadassah medical center, Jerusalem, Israel
Hagai Bergman
President, Israel society for Neuroscience (ISFN), Professor of Physiology, The Hebrew University of Jerusalem; Israel
Timothy Denison
Professor of Engineering Science, Royal Academy Chair in Emerging Technology, University of Oxford, UKTimothy Denison, PhD
Royal Academy of Engineering Chair in Emerging Technologies
Department of Engineering Science
Nuffield Department of Clinical Neuroscience
MRC Brain Network Dynamics Unit
Oxford University
Timothy Denison
Professor of Engineering Science, Royal Academy Chair in Emerging Technology, University of Oxford, UK
TBC
TBC
Networking Break
Recent theoretical work provides new insights into the computational principles that govern the dynamics of neural systems and the processing of information. This session will discuss how computational ideas can be translated into reliable neurotechnologies.
Oren Shriki
Director of MA studies and head of BA track in computer science Ben-Gurion University of the Negev The Department of Brain and Cognitive SciencesOren Shriki
Director of MA studies and head of BA track in computer science Ben-Gurion University of the Negev The Department of Brain and Cognitive Sciences
Tim Mullen
CEO & Research Director, Intheon, USA
Ilan Dinstein
Associate professor, Departments of Psychology and of Cognitive and Brain Sciences at Ben-Gurion University (BGU); Negev Autism CenterIlan Dinstein
Associate professor, Departments of Psychology and of Cognitive and Brain Sciences at Ben-Gurion University (BGU); Negev Autism Center
TBC
TBC
MATHEMATICAL NEUROSCIENCE PRIZE AWARD, IBT
NETWORKING HAPPY HOUR
Neurowellness is an emerging field focused on emotional wellbeing and resilience. There has been an exponential growth in scientific research and technological developments dedicated to understanding and enhancing the human experience. This session will explore the science behind emotional wellbeing, showcase the latest technologies in the field and discuss how these technologies will reach the individual consumer to enhance our lives.
Mike Edelhart
Managing Partner, Joyance Partners, USAMike is also the Managing Partner of Social Starts VC partnership. A pioneering media and startup executive, Mike was the original Executive Editor of PC Magazine and founding editor of other Ziff-Davis computer magazines, and later was Executive Vice President. Mike has been CEO at many startups, including Olive Software, Inman News and Zinio. At SoftBank, Mike directed content for the Seybold, Interop and Comdex conferences and launched new businesses. Mike has consulted to Bloomberg, Reuters and AARP, and has authored more than 20 books.
Mike Edelhart
Managing Partner, Joyance Partners, USA
Nanea Reeves
CEO, Co-Founder TRIPP, Inc., USA
Omri Yoffe
CEO, Vi; Founder & Chairman, C4 Systems; Founder & Chairman, Clear Cut Group, Founder, OFEK, USAOmri Yoffe
CEO, Vi; Founder & Chairman, C4 Systems; Founder & Chairman, Clear Cut Group, Founder, OFEK, USA
Nichol Bradford
Executive Director and Co-Founder The Transformative Technology Lab; CEO and Founder Willow Group, Inc., USA Short BioNichol Bradford
Executive Director and Co-Founder The Transformative Technology Lab; CEO and Founder Willow Group, Inc., USA
TBC
TBC
The field of Artificial Intelligence takes inspiration from human intelligence and from the human brain. At the same time, Artificial Intelligence is utilized to better understand and serve the human brain, and ultimately improve people’s lives. This session will give an overview of activities at the forefront of the work being done in applying brain inspired technologies in industry and will also outline how these advancements are being applied to better understand the human brain.
Amir Konigsberg
Co-Founder & President at Twiggle; Board Member, Allegro.Ai
Nilli Lavie
Professor of Psychology and Brain Sciences and Director of the Attention and Cognitive Control laboratory at the University College London Institute of Cognitive Neuroscience, UKNilli Lavie
Professor of Psychology and Brain Sciences and Director of the Attention and Cognitive Control laboratory at the University College London Institute of Cognitive Neuroscience, UK
Gal Chechik
Director of AI at NVIDIA, Associate Professor at the Gonda Brain Research Institute, Bar Ilan University, Israel Short BioGal Chechik
Director of AI at NVIDIA, Associate Professor at the Gonda Brain Research Institute, Bar Ilan University, Israel
TBC
TBC
Dana Doron
Senior physician, Sheba Stroke Unit, Tel Hashomer Hospital Functional & Structural Brain Connectivity Lab, Tel Aviv University, IsraelDana Doron
Senior physician, Sheba Stroke Unit, Tel Hashomer Hospital Functional & Structural Brain Connectivity Lab, Tel Aviv University, Israel
Sagi Harnof
Deputy Chair Department of Neurosurgery at Sheba, Tel Ha Shomer Hospital, IsraelDeputy Chair of the Department of Neurosurgery at Sheba, Tel Hashomer Hospital
Head of Neurosurgery Department at Beilinson Hospital, Rabin Medical Center (Petah-Tikva)
Sagi Harnof
Deputy Chair Department of Neurosurgery at Sheba, Tel Ha Shomer Hospital, Israel
Michal Beeri
Director, The Joseph Sagol Neuroscience Center, Sheba Medical Center, IsraelProf. Michal Beeri is a recognized world leader in the study of Alzheimer's disease. She is the Director of the Joseph Sagol Neuroscience Center at the Sheba Medical Center, Israel, and a Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, NY. The main focus of her work is discovering and manipulating factors (such as diabetes) in order to prevent Alzheimer’s disease through investigation of the neurobiology and neuropsychology of the disease. She has over 130 publications and has been continuously funded by the National Institutes of Health for over 15 years.
Michal Beeri
Director, The Joseph Sagol Neuroscience Center, Sheba Medical Center, Israel
TBC
TBC